HawkInsight

  • Contact Us
  • App
  • English

Regenxbio GAAP EPS of -$1.17 misses by $0.06, revenue of $24.2M misses by $0.2M

Regenxbio (NASDAQ:RGNX): Q3 GAAP EPS of -$1.17 misses by $0.06.Revenue of $24.2M (-16.3% Y/Y) misses by $0.2M.

Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.

NewFlashHawk Insight
More